200 related articles for article (PubMed ID: 23849321)
1. Factors influencing the implementation of antibiotic de-escalation and impact of this strategy in critically ill patients.
Gonzalez L; Cravoisy A; Barraud D; Conrad M; Nace L; Lemarié J; Bollaert PE; Gibot S
Crit Care; 2013 Jul; 17(4):R140. PubMed ID: 23849321
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and outcomes of anti-infective de-escalation during health care-associated intra-abdominal infections.
Montravers P; Augustin P; Grall N; Desmard M; Allou N; Marmuse JP; Guglielminotti J
Crit Care; 2016 Apr; 20():83. PubMed ID: 27052675
[TBL] [Abstract][Full Text] [Related]
3. De-escalation of antimicrobial therapy in ICU settings with high prevalence of multidrug-resistant bacteria: a multicentre prospective observational cohort study in patients with sepsis or septic shock.
Routsi C; Gkoufa A; Arvaniti K; Kokkoris S; Tourtoglou A; Theodorou V; Vemvetsou A; Kassianidis G; Amerikanou A; Paramythiotou E; Potamianou E; Ntorlis K; Kanavou A; Nakos G; Hassou E; Antoniadou H; Karaiskos I; Prekates A; Armaganidis A; Pnevmatikos I; Kyprianou M; Zakynthinos S; Poulakou G; Giamarellou H
J Antimicrob Chemother; 2020 Dec; 75(12):3665-3674. PubMed ID: 32865203
[TBL] [Abstract][Full Text] [Related]
4. De-escalation as part of a global strategy of empiric antibiotherapy management. A retrospective study in a medico-surgical intensive care unit.
Morel J; Casoetto J; Jospé R; Aubert G; Terrana R; Dumont A; Molliex S; Auboyer C
Crit Care; 2010; 14(6):R225. PubMed ID: 21167047
[TBL] [Abstract][Full Text] [Related]
5. Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients: a retrospective observational study.
De Bus L; Denys W; Catteeuw J; Gadeyne B; Vermeulen K; Boelens J; Claeys G; De Waele JJ; Decruyenaere J; Depuydt PO
Intensive Care Med; 2016 Jun; 42(6):1029-39. PubMed ID: 27025939
[TBL] [Abstract][Full Text] [Related]
6. A retrospective study of antibiotic de-escalation in patients with ventilator-associated pneumonia in Malaysia.
Khan RA; Aziz Z
Int J Clin Pharm; 2017 Aug; 39(4):906-912. PubMed ID: 28643112
[TBL] [Abstract][Full Text] [Related]
7. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
Eachempati SR; Hydo LJ; Shou J; Barie PS
J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
[TBL] [Abstract][Full Text] [Related]
8. De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock.
Garnacho-Montero J; Gutiérrez-Pizarraya A; Escoresca-Ortega A; Corcia-Palomo Y; Fernández-Delgado E; Herrera-Melero I; Ortiz-Leyba C; Márquez-Vácaro JA
Intensive Care Med; 2014 Jan; 40(1):32-40. PubMed ID: 24026297
[TBL] [Abstract][Full Text] [Related]
9. Collaborative approach of individual participant data of prospective studies of de-escalation in non-immunosuppressed critically ill patients with sepsis.
Gutiérrez-Pizarraya A; Leone M; Garnacho-Montero J; Martin C; Martin-Loeches I
Expert Rev Clin Pharmacol; 2017 Apr; 10(4):457-465. PubMed ID: 28266901
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic Use in the Intensive Care Unit: Optimization and De-Escalation.
Campion M; Scully G
J Intensive Care Med; 2018 Dec; 33(12):647-655. PubMed ID: 29534630
[TBL] [Abstract][Full Text] [Related]
11. Safety and Feasibility of Antibiotic De-escalation in Critically Ill Children With Sepsis - A Prospective Analytical Study From a Pediatric ICU.
Battula V; Krupanandan RK; Nambi PS; Ramachandran B
Front Pediatr; 2021; 9():640857. PubMed ID: 33763396
[No Abstract] [Full Text] [Related]
12. De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial.
Leone M; Bechis C; Baumstarck K; Lefrant JY; Albanèse J; Jaber S; Lepape A; Constantin JM; Papazian L; Bruder N; Allaouchiche B; Bézulier K; Antonini F; Textoris J; Martin C;
Intensive Care Med; 2014 Oct; 40(10):1399-408. PubMed ID: 25091790
[TBL] [Abstract][Full Text] [Related]
13. De-Escalation of Antibiotics Does Not Increase Mortality in Critically Ill Surgical Patients.
Turza KC; Politano AD; Rosenberger LH; Riccio LM; McLeod M; Sawyer RG
Surg Infect (Larchmt); 2016 Feb; 17(1):48-52. PubMed ID: 26714235
[TBL] [Abstract][Full Text] [Related]
14. [Clinical impact of ertapenem de-escalation in critically-ill patients with Enterobacteriaceae infections].
Cuesta DP; Blanco VM; Vallejo ME; Hernández-Gómez C; Maya JJ; Motoa G; Correa A; Matta L; Rosso F; Camargo RD; Muñoz M; Florez E; Nagles J; Ovalle A; Reyes S; Villegas MV
Rev Chilena Infectol; 2019 Feb; 36(1):9-15. PubMed ID: 31095199
[TBL] [Abstract][Full Text] [Related]
15. Impact of antibiotic de-escalation on hospitalized patients with urinary tract infections: A retrospective cohort single center study.
Alshareef H; Alfahad W; Albaadani A; Alyazid H; Talib RB
J Infect Public Health; 2020 Jul; 13(7):985-990. PubMed ID: 32276874
[TBL] [Abstract][Full Text] [Related]
16. De-escalation of empiric antibiotics in patients with severe sepsis or septic shock: A meta-analysis.
Guo Y; Gao W; Yang H; Ma C; Sui S
Heart Lung; 2016; 45(5):454-9. PubMed ID: 27340006
[TBL] [Abstract][Full Text] [Related]
17. Impact of the implementation of a Sepsis Code hospital protocol in antibiotic prescription and clinical outcomes in an intensive care unit.
García-López L; Grau-Cerrato S; de Frutos-Soto A; Bobillo-De Lamo F; Cítores-Gónzalez R; Diez-Gutierrez F; Muñoz-Moreno MF; Sánchez-Sánchez T; Gandía-Martínez F; Andaluz-Ojeda D;
Med Intensiva; 2017; 41(1):12-20. PubMed ID: 27771026
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic de-escalation in the ICU: how is it best done?
Garnacho-Montero J; Escoresca-Ortega A; Fernández-Delgado E
Curr Opin Infect Dis; 2015 Apr; 28(2):193-8. PubMed ID: 25692272
[TBL] [Abstract][Full Text] [Related]
19. Enhanced antimicrobial de-escalation for pneumonia in mechanically ventilated patients: a cross-over study.
Trupka T; Fisher K; Micek ST; Juang P; Kollef MH
Crit Care; 2017 Jul; 21(1):180. PubMed ID: 28709439
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
